- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02450474
Mobilising Lower Limb Fluid for Hemodynamic Stability in Haemodialysis
Pilot Evaluation of Intermittent Pneumatic Compression and Neuromuscular Electrical Stimulation for Enhancing Vascular Refilling in Haemodialysis
Cardiovascular disease is the leading cause of death of dialysis patients and poor fluid management is associated with the increased risk. One of the principal limitations in avoiding chronic fluid overload in this patient group is the refilling rate the rate at which fluid is transferred from tissues into the vascular system. If this rate cannot match the prescribed rate of fluid removal during dialysis the patient will end up with chronic fluid overload.
Two proposed methods of increasing the rate of refilling are intermittent pneumatic compression (IPC) devices, which increase the pressure of the fluid in tissue, and neuromuscular electrical stimulation (NMES) which activates the muscle pump and lymphatic drainage.
This investigation will trial the use of these two methods in patients suspected of having inadequate refilling rates. Outcome measures will be based on fluid status, presence of oedema and quality of life.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Leeds, Det Forenede Kongerige, LS9 7TF
- Rekruttering
- Leeds Teaching Hospitals NHS Trust
-
Kontakt:
- David Keane, MSc, CSci
- Telefonnummer: 01132064119
- E-mail: david.keane@nhs.net
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Presence of lower limb oedema as defined by pitting
- Average post dialysis fluid overload in relation to target weight greater than 0.5 litres
- Greater than one dialysis session that included an intradialytic hypotensive episode in the previous month, defined by saline influsion or nursing intervention
Exclusion Criteria:
- Less than 18 years of age
- Less than 3 months dialysis vintage
- Presence of metal implants, amputations or the inability to be weighed
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Diagnostisk
- Tildeling: Ikke-randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Andet: A: baseline - IPC
A: baseline - IPC - washout - NMES - washout - follow up The baseline phase, washout phase and follow up phase will consist of treatment as normal. IPC phase will consist of normal care plus IPC of the lower limbs for the duration of each dialysis session. |
Flowtron, Circulation Booster and Sports XL devices will be used.
Flowtron, Circulation Booster and Sports XL devices will be used.
|
|
Andet: B: baseline - NMES
B: baseline - NMES - washout - IPC - washout follow up The baseline phase, washout phase and follow up phase will consist of treatment as normal. NMES phase will consist of normal care plus stimulation of the foot and calf muscles for a period of one hour during dialysis. |
Flowtron, Circulation Booster and Sports XL devices will be used.
Flowtron, Circulation Booster and Sports XL devices will be used.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Fluid Status (Body composition monitor measurement of fluid status)
Tidsramme: Weekly
|
Body composition monitor measurement of fluid statu
|
Weekly
|
|
Quality of Life (Validated Kidney Disease Quality of Life (KDQOL36) quality of life measurement questionnaire and patient symptom questionnaire)
Tidsramme: Weekly
|
Validated KDQOL36 quality of life measurement questionnaire and patient symptom questionnaire
|
Weekly
|
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- RL14/11224
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Nyresvigt
-
Zhen LiTilmelding efter invitationSamtidig pancreas-Kidney-transplantationKina
-
University Hospital, Basel, SwitzerlandIkke rekrutterer endnuKardiovaskulær-Kidney-metabolsk syndrom | Cradiovascular-Kidney-Liver-Metabolic (CKLM) syndromSchweiz
-
CHU de ReimsIkke rekrutterer endnuFluid reaktionsevne i tidlig transplantationsperiode efter KidneyFrankrig
-
Chung Shan Medical UniversityNational Science and Technology Council, TaiwanIkke rekrutterer endnuFedme type 2 diabetes mellitus | Metabolisk dysfunktion-associeret steatotisk leversygdom | Kardiovaskulær-Kidney-metabolsk syndromTaiwan
-
Camille N. Kotton, MDKamada, Ltd.; University of Texas Southwestern Medical CenterRekrutteringCytomegalovirus | Nyretransplantation; Komplikationer | Organtransplantation | Levertransplantationskomplikationer | Samtidig lever-Kidney-transplantation; KomplikationerForenede Stater
-
Changhai HospitalRui Therapeutics Co., LtdRekrutteringRelapseret/Refraktær Immun Nefropati | Relapsed/Refractory Immune-mediated Kidney DiseaseKina
-
Nanjing Medical UniversityIkke rekrutterer endnuKardiovaskulær-Kidney-metabolsk syndrom
-
First Affiliated Hospital of Fujian Medical UniversityRekrutteringMetaboliske sygdomme | Kronisk nyresygdom | Hjerte-kar-sygdomme (CVD) | Kardiovaskulær-Kidney-metabolsk syndromKina
-
Chung Shan Medical UniversityNational Science and Technology Council, TaiwanAfsluttetType 2 diabetes | Nyre sygdom | Fedme & Overvægt | Risikofaktor for hjertekarsygdomme | Kardiovaskulær-Kidney-metabolsk syndrom
-
University of Alabama at BirminghamOhio State University; American Heart Association; Tuskegee UniversityRekrutteringHjerte-kar-sygdomme | Rygning | Forhøjet blodtryk | Fedme | Diabetes | Hyperlipidæmi | Nyre sygdom | Kardiovaskulær-Kidney-metabolsk syndromForenede Stater
Kliniske forsøg med Intermittent pneumatic compression device
-
Mego Afek Ltd.Afsluttet